218 related articles for article (PubMed ID: 25318477)
1. E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.
Aldi S; Marino A; Tomita K; Corti F; Anand R; Olson KE; Marcus AJ; Levi R
FASEB J; 2015 Jan; 29(1):61-9. PubMed ID: 25318477
[TBL] [Abstract][Full Text] [Related]
2. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis.
Machida T; Heerdt PM; Reid AC; Schäfer U; Silver RB; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2005 May; 313(2):570-7. PubMed ID: 15647328
[TBL] [Abstract][Full Text] [Related]
3. The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons.
Corti F; Olson KE; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2011 May; 337(2):524-32. PubMed ID: 21325440
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.
Koda K; Salazar-Rodriguez M; Corti F; Chan NY; Estephan R; Silver RB; Mochly-Rosen D; Levi R
Circulation; 2010 Aug; 122(8):771-81. PubMed ID: 20697027
[TBL] [Abstract][Full Text] [Related]
5. Interaction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunction.
Morrey C; Brazin J; Seyedi N; Corti F; Silver RB; Levi R
J Pharmacol Exp Ther; 2010 Oct; 335(1):76-84. PubMed ID: 20668055
[TBL] [Abstract][Full Text] [Related]
6. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
Yoshida K; Ito M; Matsuoka I
Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
[TBL] [Abstract][Full Text] [Related]
7. S1P receptor 1-Mediated Anti-Renin-Angiotensin System Cardioprotection: Pivotal Role of Mast Cell Aldehyde Dehydrogenase Type 2.
Marino A; Sakamoto T; Robador PA; Tomita K; Levi R
J Pharmacol Exp Ther; 2017 Aug; 362(2):230-242. PubMed ID: 28500264
[TBL] [Abstract][Full Text] [Related]
8. Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activation.
Aldi S; Takano K; Tomita K; Koda K; Chan NY; Marino A; Salazar-Rodriguez M; Thurmond RL; Levi R
J Pharmacol Exp Ther; 2014 Jun; 349(3):508-17. PubMed ID: 24696042
[TBL] [Abstract][Full Text] [Related]
9. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
10. CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease.
Shuai C; Xia GQ; Yuan F; Wang S; Lv XW
Eur J Pharmacol; 2021 Aug; 905():174198. PubMed ID: 34033815
[TBL] [Abstract][Full Text] [Related]
11. CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells.
Kuhny M; Hochdörfer T; Ayata CK; Idzko M; Huber M
Cell Commun Signal; 2014 Jul; 12():40. PubMed ID: 25184735
[TBL] [Abstract][Full Text] [Related]
12. Th2 cytokine-primed airway smooth muscle cells induce mast cell chemotaxis via secretion of ATP.
Gao YD; Cao J; Li P; Huang G; Yang J
J Asthma; 2014 Dec; 51(10):997-1003. PubMed ID: 25272186
[TBL] [Abstract][Full Text] [Related]
13. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.
Mackins CJ; Kano S; Seyedi N; Schäfer U; Reid AC; Machida T; Silver RB; Levi R
J Clin Invest; 2006 Apr; 116(4):1063-70. PubMed ID: 16585966
[TBL] [Abstract][Full Text] [Related]
14. Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.
Reid AC; Brazin JA; Morrey C; Silver RB; Levi R
Curr Pharm Des; 2011 Nov; 17(34):3744-52. PubMed ID: 22103845
[TBL] [Abstract][Full Text] [Related]
15. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
17. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
18. Salvaging the Ischemic Heart: Gi-Coupled Receptors in Mast Cells Activate a PKCε/ALDH2 Pathway Providing Anti-RAS Cardioprotection.
Marino A; Levi R
Curr Med Chem; 2018; 25(34):4416-4431. PubMed ID: 29446730
[TBL] [Abstract][Full Text] [Related]
19. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
[TBL] [Abstract][Full Text] [Related]
20. NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
Lazar Z; Müllner N; Lucattelli M; Ayata CK; Cicko S; Yegutkin GG; De Cunto G; Müller T; Meyer A; Hossfeld M; Sorichter S; Horvath I; Virchow CJ; Robson SC; Lungarella G; Idzko M
Eur Respir J; 2016 Jan; 47(1):254-63. PubMed ID: 26541524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
